Policy Positions for 2021 Rx Reform Bill
Infusion Providers Alliance2022-02-23T22:49:24+00:00The Infusion Providers Alliance (IPA) is the leading voice for [...]
The Infusion Providers Alliance (IPA) is the leading voice for [...]
The Infusion Providers Alliance (IPA) is the leading voice for [...]
The undersigned organizations, representing millions of Medicare beneficiaries with life-threatening, [...]
The Infusion Providers Alliance (IPA) appreciates the opportunity to comment [...]
Infusion Providers Alliance Responds to Most Favored Nation Drug Policy
New Requirement to Obtain Certain Drugs from CVS Specialty Pharmacy
Suspension of the Medicare sequester is key to helping providers administer critical medicines during the COVID-19 pandemic.
A new coalition of drug infusion providers has been established to advocate for policies that preserve patients’ access to infused medicines.
Infusion centers and physician offices rely on the current, well-established “buy-and-bill” distribution system that has provided uninterrupted and reliable patient access to Part B infused drugs for decades.
The Infusion Providers Alliance supports the Senate Finance Committee’s overall goals of lowering prescription drug costs for patients. However, the alliance is concerned that a coupon provision included in “The Prescription Drug Pricing Reduction Act of 2019” could increase out-of-pocket costs and make treatment less accessible